Brief: Immuneering Says On Dec 22 Entered Into A Share Purchase Agreement With Bioarkive, Inc

Immuneering

22/12/2021 18:54

Dec 22 (Reuters) - Immuneering Corp  IMRX.O :
    * IMMUNEERING - ON DEC 22 ENTERED INTO A SHARE PURCHASE
AGREEMENT
WITH BIOARKIVE, INC
    * IMMUNEERING - DUE TO DEAL UNDER SPA, ACQUIRED ALL OF
EQUITY OF
BIOARKIVE, WHICH ACCORDINGLY THEN BECAME A WHOLLY OWNED
SUBSIDIARY OF CO
    * IMMUNEERING CORP - PURCHASED ON CLOSING DATE ALL
OUTSTANDING
SHARES OF CAPITAL STOCK OF BIOARKIVE FOR PURCHASE PRICE OF $8.75
MILLION
    * IMMUNEERING - CO'S DUAL MITOGEN-ACTIVATED PROTEIN KINASE
KINASE,
PRODUCT CANDIDATE, IMM-1-104, IS CURRENTLY UNDERGOING IND
ENABLING STUDIES
    * IMMUNEERING CORP - NOW PLANS TO SUBMIT AN IND FOR
IMM-1-104 TO
FDA IN Q3 OF 2022

Further company coverage:  IMRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))